ApprovalTrail

Approval · Notice of Compliance 24136 · 2020

ZOLMITRIPTAN: Notice of Compliance 24136

Issued August 25, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
24136
Date
August 25, 2020
Company
Sanis Health Inc.Brampton, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to an Abbreviated New Drug Submission (SANDS), supplement
Submission class
Admin
Reason
Labelling update to match licensor
Canadian reference product
ZOMIG

Products in this notice

BrandDINStatus today
ZOLMITRIPTANNot yet assigned—

Medicinal ingredients